![]() |
Prostate Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Metabolic Plasticity in Prostate Cancer: The Warburg Effect and Its Clinical
Relevance.
Am J Clin Oncol. 2025 May 15. doi: 10.1097/COC.0000000000001215.
PubMed
Abstract available
Prostate cancer active surveillance in solid organ transplant: a matched study
and literature review.
BJU Int. 2025 May 14. doi: 10.1111/bju.16777.
PubMed
Abstract available
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the
Effects of Olaparib +/- Degarelix in Primary Prostate Cancer.
Clin Cancer Res. 2025 May 13:OF1-OF11. doi: 10.1158/1078-0432.CCR-24-1304.
PubMed
Abstract available
PI-QUAL version 2 image quality categorisation and inter-reader agreement
compared to version 1.
Eur Radiol. 2025;35:3096-3104.
PubMed
Abstract available
Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and
Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF):
A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 Trial.
Eur Urol. 2025 May 9:S0302-2838(25)00262-3. doi: 10.1016/j.eururo.2025.
PubMed
Single-Cell Profiling of Mononuclear Cells Identifies Transcriptomics Signatures
Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
Genes Chromosomes Cancer. 2025;64:e70051.
PubMed
Abstract available
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated
Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III,
Prospective, Randomized Controlled Trial.
J Clin Oncol. 2025 May 14:JCO2402057. doi: 10.1200/JCO-24-02057.
PubMed
Abstract available
Prostate cancer clinicopathological presentation in South-East Africa during the
2010 decade.
J Natl Cancer Inst. 2025 May 9:djaf117. doi: 10.1093.
PubMed
Abstract available
Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with
reliable positive predictive value.
J Urol. 2025 May 16:101097JU0000000000004611. doi: 10.1097/JU.0000000000004611.
PubMed
Abstract available
Interactions between androgen and IGF1 axes in prostate tumorigenesis.
Nat Rev Urol. 2025;22:268-275.
PubMed
Abstract available
Disparities in physician compensation for breast and prostate cancer operations.
PLoS One. 2025;20:e0323892.
PubMed
Abstract available
Integrating multimodal imaging and peritumoral features for enhanced prostate
cancer diagnosis: A machine learning approach.
PLoS One. 2025;20:e0323752.
PubMed
Abstract available
Analytical and Real-World Clinical Characterization of S2,3PSA% Test in MRI
Fusion Targeted Prostate Biopsy Population.
Prostate. 2025;85:869-887.
PubMed
Abstract available
Understanding Enzalutamide-Resistance Based on a Functional Single-Cell Approach.
Prostate. 2025;85:888-899.
PubMed
Abstract available
Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA
Hydroxymethylation in a Mouse Model of Prostate Cancer.
Prostate. 2025 May 11. doi: 10.1002/pros.24912.
PubMed
Abstract available
Comparison of Prostate-specific Membrane Antigen Reporting and Data System
Version 1.0 versus 2.0 for Prostate Cancer Assessment.
Radiol Imaging Cancer. 2025;7:e240390.
PubMed
Abstract available
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on
Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate
Cancer: A Secondary Analysis of the PRECISE-MDT Study.
Radiol Imaging Cancer. 2025;7:e240150.
PubMed
Abstract available
GLP-1 Agonist Use Among Men with Localized Prostate Cancer: A Narrative Review
and Rationale for Prospective Clinical Trials.
Urology. 2025 May 8:S0090-4295(25)00426-1. doi: 10.1016/j.urology.2025.
PubMed
Abstract available
Thank you for your interest in scientific medicine.